The available literature demonstrated that CDCP1 might have an immunoregulatory function that is not only relevant to tumor biology, but also potential therapeutic applications in patients with neuroinflammatory conditions and autoimmune endocrine disorders (48, 49). This evidence concerns the gene CDCP1 and neoplasm.